Charles Divita III - Jun 10, 2025 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Jun 10, 2025
Transactions value $
$0
Form type
4
Date filed
6/11/2025, 04:19 PM
Previous filing
Mar 4, 2025
Next filing
Sep 11, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DIVITA CHARLES III CHIEF EXECUTIVE OFFICER, Director C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, FLOOR 17, NEW YORK /s/ Adam C. Vandervoort, Attorney-in-Fact 2025-06-11 0001347535

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +157K 157K Jun 10, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -157K -33.33% $0.00 313K Jun 10, 2025 Common Stock 157K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.